Who Supplies Adalimumab? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Adalimumab exports, with 67+ registered manufacturers shipping to buyers across 53+ countries — yet a handful of companies dominate the shipments. ZYDUS LIFESCIENCES LIMITED holds the largest share at 27.9% (export value: $332.6K). Close behind, RELIANCE LIFE SCIENCES PRIVATE LIMITED (27.0%, $321.9K). CADILA HEALTHCARE LIMITED (11.3%, $135.2K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Adalimumab? Top Manufacturers & Their Buyers
Flow of Adalimumab from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Adalimumab Supplier Network — Key Market Intelligence
The Adalimumab export market from India is led by ZYDUS LIFESCIENCES LIMITED, which alone commands a 27.9% share, shipping $332.6K worth of product across 22 shipments. The second-largest exporter, RELIANCE LIFE SCIENCES PRIVATE LIMITED, contributes $321.9K (27.0%) to the overall market. Combined, the top two suppliers alone account for 54.9% of all Adalimumab exports, indicating a relatively concentrated supply base.
Across all 67 tracked manufacturers, the total Adalimumab export value stands at $1.2M from 223 shipments. The market average shipment value is $5.3K. The single largest buyer relationship in terms of trade value is BANK OF CEYLON - TRA, receiving $227.7K worth of product.
The combined buyer network spans 12 named purchasing companies, including BANK OF CEYLON - TRA, LEVANT PULSE, PHARMACHEM PRIVATE LIMITED, PLANET PHARMACEUTICA, ABC PHARMA SERVICES and 7 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1ZYDUS LIFESCIENCES LIMITED
ZYDUS LIFESCIENCES LIMITED is the first-largest Adalimumab exporter from India, with a market share of 27.9% and a total export value of $332.6K across 22 shipments. Their average shipment value of $15.1K is above the market average of $5.3K, suggesting premium or bulk contract pricing.
ZYDUS LIFESCIENCES LIMITED serves 1 named buyer in our database. TO THE ORDER OF PURC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF PURC — $332.6K across 22 shipments (100.0% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $15.1K is 183% above the market average of $5.3K, consistent with large-order contracts or value-added formulations.
2RELIANCE LIFE SCIENCES PRIVATE LIMITED
RELIANCE LIFE SCIENCES PRIVATE LIMITED is the second-largest Adalimumab exporter from India, with a market share of 27.0% and a total export value of $321.9K across 20 shipments. Their average shipment value of $16.1K is above the market average of $5.3K, suggesting premium or bulk contract pricing.
RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. BANK OF CEYLON - TRA is the dominant customer, accounting for 70.7% of this supplier's tracked business. Top customers include:
• BANK OF CEYLON - TRA — $227.7K across 14 shipments (70.7% of this supplier's total exports)
• LEVANT PULSE — $59.7K across 4 shipments (18.6% of this supplier's total exports)
• PHARMACHEM PRIVATE LIMITED — $18.6K across 1 shipments (5.8% of this supplier's total exports)
• PLANET PHARMACEUTICA — $8.6K across 1 shipments (2.7% of this supplier's total exports)
• ABC PHARMA SERVICES — $7.1K across 0 shipments (2.2% of this supplier's total exports)
Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $16.1K is 201% above the market average of $5.3K, consistent with large-order contracts or value-added formulations.
3CADILA HEALTHCARE LIMITED
CADILA HEALTHCARE LIMITED is the third-largest Adalimumab exporter from India, with a market share of 11.3% and a total export value of $135.2K across 4 shipments. Their average shipment value of $33.8K is above the market average of $5.3K, suggesting premium or bulk contract pricing.
CADILA HEALTHCARE LIMITED serves 2 named buyers in our database. XXALTXXAREXXHARXXCEU is the dominant customer, accounting for 87.0% of this supplier's tracked business. Top customers include:
• XXALTXXAREXXHARXXCEU — $117.6K across 3 shipments (87.0% of this supplier's total exports)
• XXTERXXLABXXNIGXXIA — $17.6K across 1 shipments (13.0% of this supplier's total exports)
Key Insight: CADILA HEALTHCARE LIMITED's per-shipment value of $33.8K is 532% above the market average of $5.3K, consistent with large-order contracts or value-added formulations.
4REMEDI PHARMA DISTRIBUTORS
REMEDI PHARMA DISTRIBUTORS is the fourth-largest Adalimumab exporter from India, with a market share of 5.2% and a total export value of $62.0K across 5 shipments. Their average shipment value of $12.4K is above the market average of $5.3K, suggesting premium or bulk contract pricing.
REMEDI PHARMA DISTRIBUTORS serves 1 named buyer in our database. DAWAA DRUG STORE LLC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• DAWAA DRUG STORE LLC — $62.0K across 5 shipments (100.0% of this supplier's total exports)
Key Insight: REMEDI PHARMA DISTRIBUTORS's per-shipment value of $12.4K is 132% above the market average of $5.3K, consistent with large-order contracts or value-added formulations.
5PHARMA CHOICE LLP
PHARMA CHOICE LLP is the fifth-largest Adalimumab exporter from India, with a market share of 4.7% and a total export value of $55.5K across 23 shipments. Their average shipment value of $2.4K is below the market average of $5.3K, reflecting a high-volume, competitive pricing strategy.
PHARMA CHOICE LLP serves 4 named buyers in our database. D. K. M. PHARMACEUTICALS PVT. LTD. is the dominant customer, accounting for 69.3% of this supplier's tracked business. Top customers include:
• D. K. M. PHARMACEUTICALS PVT. LTD. — $38.4K across 16 shipments (69.3% of this supplier's total exports)
• D. K. M. PHARMACEUTICALS PVT. LTD. — $17.0K across 7 shipments (30.6% of this supplier's total exports)
• PSK PHARMA LTD — $59 across 0 shipments (0.1% of this supplier's total exports)
• ALGENPHARM — $19 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: PHARMA CHOICE LLP operates with high shipment frequency (23 shipments) at a per-shipment value of $2.4K, indicating a broad distribution network with many smaller, regular orders.
6SPECIALITY PHARMA
SPECIALITY PHARMA is the fifth-largest Adalimumab exporter from India, with a market share of 3.1% and a total export value of $37.5K across 4 shipments. Their average shipment value of $9.4K is above the market average of $5.3K, suggesting premium or bulk contract pricing.
SPECIALITY PHARMA serves 2 named buyers in our database. D K M PHARMACEUTICALS PVT LTD is the dominant customer, accounting for 93.6% of this supplier's tracked business. Top customers include:
• D K M PHARMACEUTICALS PVT LTD — $35.1K across 4 shipments (93.6% of this supplier's total exports)
• D K M PHARMACEUTICALS PVT LTD — $2.4K across 0 shipments (6.4% of this supplier's total exports)
Key Insight: SPECIALITY PHARMA's per-shipment value of $9.4K is 75% above the market average of $5.3K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Adalimumab Flows
Once Adalimumab leaves the manufacturing plants of companies like ZYDUS LIFESCIENCES LIMITED and RELIANCE LIFE SCIENCES PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $1.2M. Venezuela absorbs the largest share at 27.9% ($332.6K), followed by Sri Lanka (20.0%) and Nepal (10.9%).
This geographic spread reflects Adalimumab's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Adalimumab Go? Top Importing Countries & Their Buyers
Trade flow of Adalimumab exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Venezuela
Venezuela ranks as the first-largest destination for Adalimumab imports from India, with a total trade value of $332.6K across 0 shipments — representing a 27.9% share of all Adalimumab exports. The average shipment value of $332.6K is above the global average of $5.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Venezuela's per-shipment average of $332.6K (6120% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Venezuela is a key market for Adalimumab imports from India.
2Sri Lanka
Sri Lanka ranks as the second-largest destination for Adalimumab imports from India, with a total trade value of $238.3K across 0 shipments — representing a 20.0% share of all Adalimumab exports. The average shipment value of $238.3K is above the global average of $5.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Sri Lanka's per-shipment average of $238.3K (4356% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Adalimumab imports from India.
3Nepal
Nepal ranks as the third-largest destination for Adalimumab imports from India, with a total trade value of $130.3K across 28 shipments — representing a 10.9% share of all Adalimumab exports. The average shipment value of $4.7K is below the global average of $5.3K, consistent with generic/API volume purchasing. This market is served by 4 tracked buyers.
Named Adalimumab importers in Nepal: D. K. M. PHARMACEUTICALS PVT. LTD. is the largest buyer, accounting for 38.2% ($49.8K) of this market's total imports.
• D. K. M. PHARMACEUTICALS PVT. LTD. — $49.8K (38.2% of Nepal's total)
• D K M PHARMACEUTICALS PRIVATE LIMITED — $35.1K (26.9% of Nepal's total)
• PHARMACHEM PRIVATE LIMITED — $22.7K (17.4% of Nepal's total)
Key Insight: Nepal receives frequent, smaller shipments of Adalimumab — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Nepal is a key market for Adalimumab imports from India.
4Bangladesh
Bangladesh ranks as the fourth-largest destination for Adalimumab imports from India, with a total trade value of $117.6K across 0 shipments — representing a 9.9% share of all Adalimumab exports. The average shipment value of $117.6K is above the global average of $5.3K, indicating high-value procurement contracts or branded formulations.
Key Insight: Bangladesh's per-shipment average of $117.6K (2099% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Bangladesh is a key market for Adalimumab imports from India.
5United Arab Emirates
United Arab Emirates ranks as the fifth-largest destination for Adalimumab imports from India, with a total trade value of $78.9K across 2 shipments — representing a 6.6% share of all Adalimumab exports. The average shipment value of $39.5K is above the global average of $5.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Adalimumab importers in United Arab Emirates: IMAD SOUHEL ANDRAOS is the largest buyer, accounting for 17.1% ($13.5K) of this market's total imports.
• IMAD SOUHEL ANDRAOS — $13.5K (17.1% of United Arab Emirates's total)
Key Insight: United Arab Emirates's per-shipment average of $39.5K (638% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Adalimumab imports from India.
People Also Ask — Adalimumab Supplier & Trade Network
Who are the top suppliers of Adalimumab from India?+
Which companies buy Adalimumab from Indian manufacturers?+
Where does Adalimumab exported from India go?+
What is the market share of the top Adalimumab supplier from India?+
What is the average shipment value for Adalimumab exports from India?+
Is Adalimumab manufactured in India and exported globally?+
Which country imports the most Adalimumab from India?+
Who are the buyers of Adalimumab in Sri Lanka?+
How concentrated is the Adalimumab supplier market in India?+
How do I find verified buyers for Adalimumab in specific countries?+
Adalimumab Trade Network — Key Takeaways
- 1ZYDUS LIFESCIENCES LIMITED is India's dominant Adalimumab exporter with a 27.9% market share and $332.6K in total exports — making it the single most important sourcing entity in this market.
- 2The top 67 suppliers collectively account for 79.2% of all tracked Adalimumab exports, with a combined trade value of $1.2M.
- 3Venezuela is the largest destination market, absorbing 27.9% of India's Adalimumab exports ($332.6K). Sri Lanka (20.0%) and Nepal (10.9%) follow.
- 4With 223 total shipments averaging $5.3K each, the Adalimumab export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include BANK OF CEYLON - TRA, LEVANT PULSE, XXALTXXAREXXHARXXCEU, XXTERXXLABXXNIGXXIA — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 53 countries
Network value: $1.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Adalimumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Adalimumab.
- 2.Flow Mapping: 67 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 223 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 53 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
223 Verified Shipments
67 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists